Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.2174/1570159X15666170707155345 | ||||
| Año | 2018 | ||||
| Tipo | revisión |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Conclusion: Advances in molecular biology have uncovered the potential molecular pathways involved in the aging process. Due to their characteristics, invertebrate models are mainly used for drug screening. The National Institute on Aging (NIA) developed the Interventions Testing Program (ITP). At the preclinical level, the ITP uses Heterogeneous mouse model (HET) which is probably the most suitable rodent model to study potential drugs against aging prevention. The accelerated-senescence mouse P8 is also a mammalian rodent model for aging research. However, when evaluating the effect of drugs on a preclinical level, the evaluation must be done in non-human primates since it is the mammalian specie closest to humans. Research is needed to investigate the impact of new potential drugs for the increase of human quality of life.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Folch, Jaume | Hombre |
Univ Rovira & Virgili - España
Biomed Res Networking Ctr Neurodegenerat Dis CIBE - España Universitat Rovira i Virgili, Facultat de Medicina i Ciencies de la Salut - España CIBER Enfermedades Neurodegenerativas - España Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas - España |
| 2 | Busquets, Oriol | Hombre |
Univ Barcelona - España
Univ Rovira & Virgili - España Biomed Res Networking Ctr Neurodegenerat Dis CIBE - España Universitat de Barcelona - España Universitat Rovira i Virgili, Facultat de Medicina i Ciencies de la Salut - España CIBER Enfermedades Neurodegenerativas - España Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas - España |
| 3 | Ettcheto, Miren | Mujer |
Univ Barcelona - España
Univ Rovira & Virgili - España Biomed Res Networking Ctr Neurodegenerat Dis CIBE - España Universitat de Barcelona - España Universitat Rovira i Virgili, Facultat de Medicina i Ciencies de la Salut - España CIBER Enfermedades Neurodegenerativas - España Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas - España |
| 4 | Sanchez-Lopez, Elena | Mujer |
Biomed Res Networking Ctr Neurodegenerat Dis CIBE - España
Univ Barcelona - España CIBER Enfermedades Neurodegenerativas - España Universitat de Barcelona - España Institut de Nanociencia i Nanotecnologia - España Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas - España Instituto de Nanociencia y Nanotecnología Universitat de Barcelona - España |
| 5 | Pallas, Merce | - |
Univ Barcelona - España
Biomed Res Networking Ctr Neurodegenerat Dis CIBE - España Universitat de Barcelona - España CIBER Enfermedades Neurodegenerativas - España Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas - España |
| 6 | Sureda, Francesc X. | Hombre |
Univ Guadalajara - México
|
| 7 | MARIN-GOMEZ, MIGUEL | Hombre |
Univ Nacl Loja - Ecuador
Universidad Nacional de Loja - Ecuador |
| 8 | Casadesus, Gemma | Mujer |
Kent State Univ - Estados Unidos
Kent State University - Estados Unidos |
| 9 | Oquequi, Jordi | Hombre |
Universidad Autónoma de Chile - Chile
|
| 10 | Auladell, Carme | Mujer |
Univ Barcelona - España
Univ Guadalajara - México Universitat de Barcelona - España Universidad de Guadalajara - México |
| 11 | Camins, Antoni | Hombre |
Univ Barcelona - España
Biomed Res Networking Ctr Neurodegenerat Dis CIBE - España Univ Nacl Loja - Ecuador Universitat de Barcelona - España CIBER Enfermedades Neurodegenerativas - España Universidad Nacional de Loja - Ecuador Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas - España |
| Fuente |
|---|
| Generalitat de Catalunya |
| European Regional Development Founds |
| NIA |
| Spanish Ministry for the PhD scholarship FPI-MICINN |
| ESL |
| Spanish Ministry of Science and Innovation project |
| FPI-MICINN |
| Non Human Primate National Institute on Aging Parkinson’s disease Protein Kinase |
| Agradecimiento |
|---|
| The author, ESL, acknowledges the support of the Spanish Ministry for the PhD scholarship FPI-MICINN (BES-2012-056083). The authors are grateful to Roxanne Rowles for the English revision of the manuscript. |
| Catalase Coenzime Q Drosophila melanogaster Dietary Restriction Endoplasmic Reticulum Growth Hormone Huntington disease Heterogeneous Mice Model Insulin Growth Factor 1 Interleukin-1beta Interleukin-6 Interventions Testing Program level Jun N-terminal Kinase Liver Kinase B1 Mammalian Target of Rapamycin Nicotinamide adenine nucleotide Non Human Primate National Institute on Aging Parkinson’s disease Protein Kinase B paraoxonase1 Resveratrol Reactive oxygen species Sirtuin 1 Superoxide dismutase Type 2 Diabetes Mellitus Tumor necrosis factors alpha Thyroid Stimulating Hormone Unfolded Protein Response The author, ESL, acknowledges the support of the Spanish Ministry for the PhD scholarship FPI-MICINN (BES-2012-056083). The authors are grateful to Roxanne Rowles for the English revision of the manuscript. |